Methods for promoting dopaminergic neuronal development by using NG4A-subfamily and Wnt-ligands
Details for Australian Patent Application No. 2003269354 (hide)
International Classifications
Event Publications
15 January 2004 Complete Application Filed
Priority application(s): 0222162.0 24.09.02 GB; 60/413,046 24.09.02 US; 60/494,595 12.08.03 US
20 May 2004 Application Open to Public Inspection
Published as AU-B-2003269354
23 June 2005 Section 223 Application Allowed
NEURO THERAPEUTICS AB The time in which to enter the National Phase has been extended to 24 May 2005. Address for service in Australia - Davies Collison Cave 1 Nicholson MELStreet BOURNE VIC 3000
6 March 2008 Application Accepted
Published as AU-B-2003269354
3 July 2008 Standard Patent Sealed
22 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003269355-HYDROGEN STORAGE MATERIAL WITH HIGH STORAGE CAPACITY
2003269353-DIAGNOSIS OF GLAUCOMA BY COMPLEX AUTOANTIBODY REPERTOIRES IN BODY FLUIDS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser